Lower levels of plasma syndecan-4 are associated with loss of body weight and fat-free mass after bariatric surgery.
BMC Res Notes
; 17(1): 164, 2024 Jun 15.
Article
en En
| MEDLINE
| ID: mdl-38879520
ABSTRACT
OBJECTIVE:
Bariatric surgery induces a significant loss of both fat mass (FM) and fat-free mass (FFM). The proteoglycan receptor syndecan-4 (SDC4) plays a crucial role in adipose tissue and skeletal muscle functions. Thus, this study was performed (i) to assess plasma SDC4 levels after both Sleeve Gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) surgeries, and (ii) to explore potential associations with changes in body composition variables.RESULTS:
Twenty-six patients (17 females) with severe obesity underwent SG (n = 13) or RYGB (n = 13) and were followed up to 1 year (1Y). Body weight, FM, FFM, and SCD4 were measured at baseline (BL), and at week 11 (W11) and 1Y after surgery. Independently of procedure, there was a significant body weight loss at W11, with an average FM and FFM reduction of 13.7 ± 0.6 kg and 5.3 ± 0.5 kg, respectively. Participants continued to lose weight afterwards, with a total weigth loss of 38.2 ± 1.5 kg at 1Y. No associations were found at BL between SDC4 levels and any anthropometric variable; however, SDC4 levels were lower than BL at both W11 and 1Y, independently of type of surgery. Additionally, changes in SDC4 between BL and 1Y were positively correlated with weight and FFM loss during the same period. TRIAL REGISTRATION ClinicalTrials.gov NCT04051190 on 09/08/2019.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Pérdida de Peso
/
Cirugía Bariátrica
/
Sindecano-4
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
BMC Res Notes
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos